Effect of the L-Arginine-Nitric Oxide Pathway on Human Placental Vascular Tone and Corticotropin-Releasing Hormone Secretion

References

• Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249–58
   PubMed Web of Science ®Google Scholar
• Conrad KP, Joffe GM, Krusznya H, Krusznya R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB 1993; 7: 566–71
   PubMed Web of Science ®Google Scholar
• Kopp L, Paradiz G, Tucci JR. Urinary excretion of cyclic 3′,5′-adenosine monophosphate and cyclic 3′,5′-guanosine monophosphate during and after pregnancy. J Clin Endocrinol Metab 1977; 44: 249–58
   Google Scholar
• Busse R, Mulsch A, Fleming I, Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation 1993; 87: V18–25
   Web of Science ®Google Scholar
• Myatt L. Control of vascular resistance in the human placenta. Placenta 1993; 13: 329–41
   Google Scholar
• Boura A LA, Walters W AW, Read MA, Leitch IM. Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 1994; 21: 737–48
   PubMed Web of Science ®Google Scholar
• Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hyperten 1991; 4: 700–8
   PubMed Web of Science ®Google Scholar
• Lyall L, Greer IA. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev Reprod 1996; 1: 107–16
   PubMedGoogle Scholar
• Brown MA. The physiology of pre-eclampsia. Clin Exp Pharmacol Physiol 1995; 22: 781–91
   PubMed Web of Science ®Google Scholar
• Brennecke SP, Dilulio JL, Gude NM, King RG. Nitric oxide synthase activity of preterm human placental tissue is reduced in pre-eclampsia. Placenta 1994; 15: A6
   Google Scholar
• Pinto A, Sorrentino R, Sorrentino P, Guerritore T, Miranda L, Biondi A, et al. Endothelial-derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension. Am J Obstet Gynecol 1991; 164: 507–13
   PubMed Web of Science ®Google Scholar
• Fickling SA, Williams D, Vallance P, Nussey SS, Whitely GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet 1993; 342: 242–3
   PubMed Web of Science ®Google Scholar
• Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1458–66
   PubMed Web of Science ®Google Scholar
• Yallampalli CH, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy poduces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169: 1316–20
   PubMed Web of Science ®Google Scholar
• Molnar M, Hertelendy FN. omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992; 166: 1560–7
   PubMed Web of Science ®Google Scholar
• Neri I, Di Renzo GC, Caserta G, Gallinelli A, Facchinetti F. Impact of the L-arginine/nitric-oxide system in pregnancy. Obstet Gynecol Surv 1995; 50: 851–8
   PubMedGoogle Scholar
• Jeske W, Soszynski P, Lukaszewicz E, Debski R, Latoszewska W, Rogozinski W, et al. Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinologica 1990; 122: 711–4
   PubMedGoogle Scholar
• Ruth V, Hallman M, Laatikainen T. Corticotropin-releasing hormone and Cortisol in cord plasma in relation to gestational age, labor and fetal distress. Am J Perinatol 1993; 10: 115–8
   PubMed Web of Science ®Google Scholar
• Sasaki A, Sinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, et al. Immunoreactive corticotrophin-releasing hormone in human plasma during pregnancy, labour and delivery. J Clin Endocrinol Metab 1987; 64: 224–9
   PubMed Web of Science ®Google Scholar
• Campbell EA, Linton EA, Wolfe C, Scraggs PR, Jones MT, Lowry PJ. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 1987; 64: 1054–9
   PubMed Web of Science ®Google Scholar
• Frim DM, Emanuel RL, Robinson BG, Smas CM, Alder GK, Majzoub JA. Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta. J Clin Invest 1988; 82: 287–92
   PubMed Web of Science ®Google Scholar
• Quartero H WP, Fry CH. Placental corticotropin releasing factor may modulate human parturition. Placenta 1989; 10: 439–43
   PubMed Web of Science ®Google Scholar
• McLean M, Bisits A, Davies J, Lowry P, Smith R. A placental clock controlling the length of pregnancy. Nature Medicine 1995; 1: 460–3
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM, Giles WG, Boura A LA, Robinson P, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphatemediated pathway. J Clin Endo Metab 1995; 80: 2888–93
   PubMed Web of Science ®Google Scholar
• Petraglia F, Sawchenko PE, Rivier J, Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 1987; 328: 719–9
   Google Scholar
• Myatt L, Brockman DE, Eis A LW, Pollack JS. Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 1993; 14: 487–95
   PubMed Web of Science ®Google Scholar
• Riley SC, Walton JC, Herlick JM, Challis J RG. The localization, and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J Clin Endocrinol Metab 1991; 72: 1001–7
   PubMed Web of Science ®Google Scholar
• Eis AL, Brockman DE, Pollack JS, Myatt L. Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta 1995; 16: 113–26
   PubMed Web of Science ®Google Scholar
• Leitch IM, Read MA, Boura A LA, Walters W AW. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Clin Exp Pharmacol Physiol 1994; 21: 615–22
   Google Scholar
• Roe CM, Leitch IM, Boura A LA, Smith R. Nitric oxide regulation of corticotrophinreleasing hormone release from the human perfused placenta in vitro. J Clin Endo Metab 1996; 81: 763–9
   PubMed Web of Science ®Google Scholar
• Sokal RR, Rohlf F, Biometry G. The Principles and Practice of Statistics in Biological Research2nd ed. W.H. Freeman and Co., San Francisco 1981; 209–70
   Google Scholar
• Rees DD, Palmer RM, Schultz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746–52
   PubMed Web of Science ®Google Scholar
• Myatt L, Brewer A, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 1991; 164: 687–92
   PubMed Web of Science ®Google Scholar
• Gude NM, King RG, Brennecke SP. Role of endothelium-derived nitric oxide in the maintenance of low fetal vascular resistance in placenta. Lancet 1990; 336: 1589–90
   PubMed Web of Science ®Google Scholar
• Gonzales C, Cruz MA, Gallardo V, Lagos M, Varela J, Albornoz J, et al. Nitric oxide and prostaglandin systems inhibition on the isolated perfused human placenta from normal and preeclamptic pregnancies. Gynecol Obstet Invest 1995; 40: 244–8
   Google Scholar
• Hishikawa K, Nakaki T, Suzuki H, Saruta T, Kato R. L-arginine-induced hypotension. Lancet 1991; 337: 683–4
   PubMed Web of Science ®Google Scholar
• Hishikawa K, Nakaki T, Suzuki H, Kato R, Saruta T. L-arginine as a antihypertensive agent. J Cardiovasc Pharmacol 1992; 20: S196–7
   Google Scholar
• Sun K, Smith R, Robinson PJ. Basal and KCl-stimulated corticotropin-releasing hormone release from human placental syncytiotrophoblasts is inhibited by sodium nitroprusside. J Clin Endocrinol Metab 1994; 79: 519–24
   PubMedGoogle Scholar
• Cetin I, Marconi AM, Corbetta C, Baggiani AM, Battaglia FC, Pardi G. Fetalmaternal amino acid relationships in normal and intrauterine growth retarded (IUGR) pregnancies. Trophoblast Research 1993; 7: 11–23
   Google Scholar
• Barnardini I, Evans MI, Nicolaides KH, Economides DL, Gahl WA. The fetal concentrating index as a gestational age-independent measure of placental dysfunction in intrauterine growth retardation. Am J Obstet Gynecol 1991; 164: 1481–90
   Google Scholar
• Enders RH, Judd RM, Donohue TM, Smith CH. Placental amino acid uptake. III. Transport systems for neutral amino acids. Am J Physiol 1976; 230: 706–10
   PubMed Web of Science ®Google Scholar
• Yuldilevich DL, Sweiry JH. Transport of amino acids in the placenta. Biochimica et Biophysica Acta 1985; 822: 169–201
   Google Scholar
• Giles WB, McClean M, Davies JJ, Smith R. Abnormal umbilical artery Doppler waveforms and cord blood corticotropin-releasing hormone. Obstet Gynecol 1996; 87: 107–11
   PubMed Web of Science ®Google Scholar
• Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW. Cloning and characterization of the cDNAs for human and rat corticotropin-releasing factorbinding proteins. Nature 1991; 349: 423–6
   PubMedGoogle Scholar
• Goland RS, Jozak S, Conwell I. Placental corticotropin-releasing hormone and hypercortisolism of pregnancy. Am J Obset Gynecol 1994; 171: 1287–91
   PubMed Web of Science ®Google Scholar
• Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW. Corticotropinreleasing hormone and corticotropin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies. Br J Obstet Gynaecol 1995; 102: 118–22
   PubMedGoogle Scholar